441 related articles for article (PubMed ID: 29777854)
21. Intradermal Delivery of a Near-Infrared Photosensitizer Using Dissolving Microneedle Arrays.
Hamdan IMN; Tekko IA; Matchett KB; Arnaut LG; Silva CS; McCarthy HO; Donnelly RF
J Pharm Sci; 2018 Sep; 107(9):2439-2450. PubMed ID: 29864428
[TBL] [Abstract][Full Text] [Related]
22. Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium.
Gomaa YA; Garland MJ; McInnes F; El-Khordagui LK; Wilson C; Donnelly RF
Eur J Pharm Biopharm; 2012 Oct; 82(2):299-307. PubMed ID: 22836025
[TBL] [Abstract][Full Text] [Related]
23. A tearable dissolving microneedle system for shortening application time.
Lee WJ; Han MR; Kim JS; Park JH
Expert Opin Drug Deliv; 2019 Mar; 16(3):199-206. PubMed ID: 30773938
[TBL] [Abstract][Full Text] [Related]
24. Fabrication of polyvinyl pyrrolidone-K90/Eudragit RL100-based dissolving microneedle patches loaded with alpha-arbutin and resveratrol for skin depigmentation.
Aung NN; Pengnam S; Ngawhirunpat T; Rojanarata T; Patrojanasophon P; Opanasopit P; Pamornpathomkul B
Biomater Sci; 2023 Jun; 11(13):4583-4601. PubMed ID: 37183632
[TBL] [Abstract][Full Text] [Related]
25. IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery.
Mönkäre J; Reza Nejadnik M; Baccouche K; Romeijn S; Jiskoot W; Bouwstra JA
J Control Release; 2015 Nov; 218():53-62. PubMed ID: 26437262
[TBL] [Abstract][Full Text] [Related]
26. Rapidly separating microneedles for transdermal drug delivery.
Zhu DD; Wang QL; Liu XB; Guo XD
Acta Biomater; 2016 Sep; 41():312-9. PubMed ID: 27265152
[TBL] [Abstract][Full Text] [Related]
27. Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs.
Anjani QK; Permana AD; Cárcamo-Martínez Á; Domínguez-Robles J; Tekko IA; Larrañeta E; Vora LK; Ramadon D; Donnelly RF
Eur J Pharm Biopharm; 2021 Jan; 158():294-312. PubMed ID: 33309844
[TBL] [Abstract][Full Text] [Related]
28. HPMC/PVP Dissolving Microneedles: a Promising Delivery Platform to Promote Trans-Epidermal Delivery of Alpha-Arbutin for Skin Lightening.
Aung NN; Ngawhirunpat T; Rojanarata T; Patrojanasophon P; Opanasopit P; Pamornpathomkul B
AAPS PharmSciTech; 2019 Dec; 21(1):25. PubMed ID: 31848807
[TBL] [Abstract][Full Text] [Related]
29. Two-Photon Polymerisation 3D Printing of Microneedle Array Templates with Versatile Designs: Application in the Development of Polymeric Drug Delivery Systems.
Cordeiro AS; Tekko IA; Jomaa MH; Vora L; McAlister E; Volpe-Zanutto F; Nethery M; Baine PT; Mitchell N; McNeill DW; Donnelly RF
Pharm Res; 2020 Aug; 37(9):174. PubMed ID: 32856172
[TBL] [Abstract][Full Text] [Related]
30. Feasibility of Enhancing Skin Permeability of Acyclovir through Sterile Topical Lyophilized Wafer on Self-Dissolving Microneedle-Treated Skin.
Nagra U; Barkat K; Ashraf MU; Shabbir M
Dose Response; 2022; 20(2):15593258221097594. PubMed ID: 35602585
[TBL] [Abstract][Full Text] [Related]
31. Formulation of two-layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice.
Lee IC; Lin WM; Shu JC; Tsai SW; Chen CH; Tsai MT
J Biomed Mater Res A; 2017 Jan; 105(1):84-93. PubMed ID: 27539509
[TBL] [Abstract][Full Text] [Related]
32. Processing difficulties and instability of carbohydrate microneedle arrays.
Donnelly RF; Morrow DI; Singh TR; Migalska K; McCarron PA; O'Mahony C; Woolfson AD
Drug Dev Ind Pharm; 2009 Oct; 35(10):1242-54. PubMed ID: 19555249
[TBL] [Abstract][Full Text] [Related]
33. Design of a Dissolving Microneedle Platform for Transdermal Delivery of a Fixed-Dose Combination of Cardiovascular Drugs.
Quinn HL; Bonham L; Hughes CM; Donnelly RF
J Pharm Sci; 2015 Oct; 104(10):3490-500. PubMed ID: 26149914
[TBL] [Abstract][Full Text] [Related]
34. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
Hull CM; Brunton S
Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
[TBL] [Abstract][Full Text] [Related]
35. Development of a Novel Self-Dissolving Microneedle-Assisted Percutaneous Delivery System of Diacerein through Solid Dispersion Gel: Solubility Enhancement, Proof of Anti-inflammatory Activity and Safety.
Shabbir M; Barkat K; Ashraf MU; Nagra U
Curr Drug Deliv; 2023; 20(9):1351-1367. PubMed ID: 35770410
[TBL] [Abstract][Full Text] [Related]
36. Soluplus micelles for acyclovir ocular delivery: Formulation and cornea and sclera permeability.
Varela-Garcia A; Concheiro A; Alvarez-Lorenzo C
Int J Pharm; 2018 Dec; 552(1-2):39-47. PubMed ID: 30253214
[TBL] [Abstract][Full Text] [Related]
37. Improvement of transdermal delivery of sumatriptan succinate using a novel self-dissolving microneedle array fabricated from sodium hyaluronate in rats.
Wu D; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Biol Pharm Bull; 2015; 38(3):365-73. PubMed ID: 25757917
[TBL] [Abstract][Full Text] [Related]
38. Comparative efficacy evaluation of different penetration enhancement strategies for dermal delivery of poorly soluble drugs - A case with sertaconazole nitrate.
Bubić Pajić N; Vucen S; Ilić T; O'Mahony C; Dobričić V; Savić S
Eur J Pharm Sci; 2021 Sep; 164():105895. PubMed ID: 34087357
[TBL] [Abstract][Full Text] [Related]
39. Fabrication, characterization and comparison of α-arbutin loaded dissolving and hydrogel forming microneedles.
Aung NN; Ngawhirunpat T; Rojanarata T; Patrojanasophon P; Pamornpathomkul B; Opanasopit P
Int J Pharm; 2020 Aug; 586():119508. PubMed ID: 32512227
[TBL] [Abstract][Full Text] [Related]
40. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery.
Yan G; Warner KS; Zhang J; Sharma S; Gale BK
Int J Pharm; 2010 May; 391(1-2):7-12. PubMed ID: 20188808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
